The Press Release Resource

POINT ROBERTS, Wash., May 20,2011 – www.InvestorIdeas.com, a leader in investor research including biotech and stem cell stocks, issues a Q&A with Dr. James Musick, Chief Executive Officer of stem cell company, Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG). Q Investorideas.com Your company’s stem cell technology focuses on adult stem cells that are derived …

WORCESTER, MA – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today that human embryonic stem cell (hESC) line MA135 was unanimously approved for federal funding at the 100th Meeting of the Advisory Committee to the Director (ACD) National Institutes of Health (NIH).  In addition to MA135, seven additional stem cell lines derived at ACT …

WORCESTER — Advanced Cell Technology, Inc. (OTCBB: ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine, announced that company Chairman and Chief Executive Officer William M. Caldwell IV was interviewed yesterday on Bloomberg Radio’s popular mid-day program, The Hays Advantage, hosted by Kathleen Hays. The discussion covered Advanced Cell’s retinal pigment …

Analyst Briefing on Global Stem Cells Market by MarketsandMarkets.

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies.

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies.